California
Novartis Pharmaceuticals Corp plans to build a biomedical research and development installation in San Diego. The scope of the biomedical research project of $ 1.1 billion of $ 1.1 billion includes the design and construction of the building space; Buy and installation of smoke hoods, stainless steel pipes, cooling/freezers and wet laboratory, formulation, tests, leaks and air handling systems. A construction calendar is being developed; The completion of the project is expected in 2028 or 2029. Novartis, which will use the installation for research and development, plans to build four manufacturing plants in North -American -American places. Novartis Pharmaceuticals Corp americas, 1 Health Plaza, East Hanover NJ 07936, Il#CA250601
Mission
Entcy Mississippi, Inc. It plans to build a natural cycle power plant, natural gas and electric substation in a 75 -hectare place in Ridgeland. The estimated range of $ 1 billion project includes building building space, team foundations and spill containment systems; Installation of turbine and combustion generators, heat recovery vapor and steam turbines and generators; and the purchase and installation of water treatment and storage systems, cooling towers, transformers, switching control equipment and emissions. It is expected that the preparation of the site for the estimated plant of 760 MW will begin in the third quarter of 2025, and the construction is expected to begin in 2026. Entergy Mississippi, Inc., 9425 Pinetroft Drive, the Woodlands Tx 77380, Il#MS250409
Texas
Eli Lilly and Co. It is planned to build a manufacturing campus of $ 5.9 million active pharmaceuticals (API) in a place of 236 hectares in the Park Generation in Houston. The scope of the project includes the design and construction of several buildings with clean room space, offices, tanks estate, central floor of use and treatment of wastewater, production and oligomerization; In addition to the purchase and installation of stainless steel deposits and pipes, chemical storage tanks, reactors, process and filtration vessels, purification, filling, packaging and wastewater treatment systems and systems. Construction is expected to begin by 2026. The project is part of the planned investment of $ 28 billion from Eli Lilly and Co. In new manufacturing facilities in the United States Eli Lilly and Co., 893 Delaware St., Indianapolis in 46285, Il#TX250524
